BCM
MRNA icon

Blume Capital Management’s Moderna MRNA Stock Holding History

Blume Capital Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.15K Hold
45
– – ﹤0.01% 315
2026
Q1 		$2.29K Hold
45
– – ﹤0.01% 306
2025
Q4 		$1.33K Hold
45
– – ﹤0.01% 309
2025
Q3 		$1.16K Hold
45
– – ﹤0.01% 326
2025
Q2 		$1.24K Sell
45
-4
-8% -$105 ﹤0.01% 354
2025
Q1 		$1.39K Buy
49
+4
+9% +$142 ﹤0.01% 348
2024
Q4 		$1.87K Hold
45
– – ﹤0.01% 307
2024
Q3 		$3.01K Hold
45
– – ﹤0.01% 320
2024
Q2 		$5.34K Hold
45
– – ﹤0.01% 273
2024
Q1 		$4.8K Buy
+45
New +$4.54K ﹤0.01% 276
2021
Q1 		– Sell
-2
Closed – – 267
2020
Q4 		$0 Buy
+2
New +$202 ﹤0.01% 231

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Blume Capital Management's MRNA Position: Q2 2026 in Review

Blume Capital Management held its Moderna (MRNA) position steady in Q2 2026 at 45 shares worth $3.15K. The position accounts for ﹤0.01% of the portfolio, ranked #315.

Blume Capital Management first reported a position in MRNA in Q4 2020 and has held it in 11 quarters since. The position peaked at $5.34K in Q2 2024. 780 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Blume Capital Management held 45 shares of Moderna worth $3.15K as of Q2 2026.
  • Blume Capital Management left its Moderna share count unchanged in Q2 2026.
  • Moderna made up ﹤0.01% of Blume Capital Management's portfolio in Q2 2026, its #315 holding.
  • Blume Capital Management first reported a position in Moderna in Q4 2020 and has held it in 11 quarters since.
  • Blume Capital Management's Moderna position peaked at $5.34K in Q2 2024.
  • 780 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Blume Capital Management's 13F filing for Q2 2026, filed 27 Jul 2026.